Controversy around how any future COVID-19 vaccines should be allocated between countries has been fueled by Sanofi’s CEO after he said the US would have priority for his company's product.
Paul Hudson said longstanding funding from the US Biomedical Advanced Research and Development Authority (BARDA), which expanded its partnership with...






